CLEARSIDE BIOMEDICAL, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.24 USD | -8.17% |
|
-5.34% | +5.98% |
| Apr. 16 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
| Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Clearside Biomedi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The Company is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD), is in Phase 2b clinical testing. It developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.
Calendar
2024-05-14
- Citizens JMP Life Sciences Conference
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.35
USD
Average target price
5.4
USD
Spread / Average Target
+300.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.98% | 101M | |
| +3.28% | 108B | |
| +11.08% | 104B | |
| +1.28% | 22.33B | |
| -11.94% | 22.19B | |
| -7.05% | 18.69B | |
| -38.36% | 17.74B | |
| -10.04% | 17.64B | |
| +4.30% | 14.05B | |
| +34.95% | 12.51B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc. - Special Call